 3. Histologically or cytologically confirmed, locally advanced or metastatic colorectal cancer CRC that is documented to be without Kirsten rat sarcoma KRAS or Neuroblastoma rat sarcoma NRAS gene mutations i.e. tumors must express the KRAS and NRAS wild type WT, exon 2, 3 and 4. 